Abdelnaby, R.M.; Rateb, H.S.; Ali, O.; Saad, A.S.; Nadeem, R.I.; Abou-Seri, S.M.; Amin, K.M.; Younis, N.S.; Abdelhady, R.
Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells. Pharmaceuticals 2022, 15, 428.
https://doi.org/10.3390/ph15040428
AMA Style
Abdelnaby RM, Rateb HS, Ali O, Saad AS, Nadeem RI, Abou-Seri SM, Amin KM, Younis NS, Abdelhady R.
Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells. Pharmaceuticals. 2022; 15(4):428.
https://doi.org/10.3390/ph15040428
Chicago/Turabian Style
Abdelnaby, Rana M., Heba S. Rateb, Omaima Ali, Ahmed S. Saad, Rania I. Nadeem, Sahar M. Abou-Seri, Kamilia M. Amin, Nancy S. Younis, and Rasha Abdelhady.
2022. "Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells" Pharmaceuticals 15, no. 4: 428.
https://doi.org/10.3390/ph15040428
APA Style
Abdelnaby, R. M., Rateb, H. S., Ali, O., Saad, A. S., Nadeem, R. I., Abou-Seri, S. M., Amin, K. M., Younis, N. S., & Abdelhady, R.
(2022). Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells. Pharmaceuticals, 15(4), 428.
https://doi.org/10.3390/ph15040428
